Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- Check7 days agoChange DetectedThe revision tag on the page changed from v3.6.0 to v3.6.3. This reflects a minor update to the page's documentation/metadata rather than its content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision tag was updated to v3.6.0. The wording of the 'Intervention/Treatment' section was standardized from 'Intervention / Treatment', and older labels such as 'Verified' and 'Last known status was:' were removed.SummaryDifference2%

- Check28 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new build of the page. This reflects a minor update to the page's version.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision number was updated from v3.5.3 to v3.5.4, indicating a small backend/documentation update without altering study information.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov site revision (from v3.5.0 to v3.5.3).SummaryDifference0.1%

- Check107 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3. This metadata update does not alter any study content or page functionality.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.